Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Polygenic Risk Scores Differentiating Schizophrenia From Bipolar Disorder Are Associated With Premorbid Intelligence in Schizophrenia Patients and Healthy Subjects.
Ohi K, Nishizawa D, Sugiyama S, Takai K, Kuramitsu A, Hasegawa J, Soda M, Kitaichi K, Hashimoto R, Ikeda K, Shioiri T. Ohi K, et al. Among authors: hasegawa j. Int J Neuropsychopharmacol. 2021 Jul 23;24(7):562-569. doi: 10.1093/ijnp/pyab014. Int J Neuropsychopharmacol. 2021. PMID: 33738471 Free PMC article.
Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach.
Ohi K, Nishizawa D, Sugiyama S, Takai K, Fujikane D, Kuramitsu A, Hasegawa J, Soda M, Kitaichi K, Hashimoto R, Ikeda K, Shioiri T. Ohi K, et al. Among authors: hasegawa j. Psychol Med. 2023 Jul;53(10):4454-4463. doi: 10.1017/S0033291722001271. Epub 2022 Aug 16. Psychol Med. 2023. PMID: 35971752
Genome-wide DNA methylation risk scores for schizophrenia derived from blood and brain tissues further explain the genetic risk in patients stratified by polygenic risk scores for schizophrenia and bipolar disorder.
Ohi K, Shimada M, Soda M, Nishizawa D, Fujikane D, Takai K, Kuramitsu A, Muto Y, Sugiyama S, Hasegawa J, Kitaichi K, Ikeda K, Shioiri T. Ohi K, et al. Among authors: hasegawa j. BMJ Ment Health. 2024 Jan 11;27(1):e300936. doi: 10.1136/bmjment-2023-300936. BMJ Ment Health. 2024. PMID: 38216218 Free PMC article.
Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies.
Nishizawa D, Kasai S, Hasegawa J, Sato N, Yamada H, Tanioka F, Nagashima M, Katoh R, Satoh Y, Tagami M, Ujike H, Ozaki N, Inada T, Iwata N, Sora I, Iyo M, Yamada M, Kondo N, Won MJ, Naruse N, Uehara-Aoyama K, Itokawa M, Ohi K, Hashimoto R, Tanisawa K, Arai T, Mori S, Sawabe M, Naka-Mieno M, Yamada Y, Yamada M, Sato N, Muramatsu M, Tanaka M, Irukayama-Tomobe Y, Saito YC, Sakurai T, Hayashida M, Sugimura H, Ikeda K. Nishizawa D, et al. Among authors: hasegawa j. Mol Brain. 2015 Aug 20;8:50. doi: 10.1186/s13041-015-0142-x. Mol Brain. 2015. PMID: 26289589 Free PMC article.
Genetic associations of single nucleotide polymorphisms in the l-DOPA receptor (GPR143) gene with severity of nicotine dependence in Japanese individuals, and attenuation of nicotine reinforcement in Gpr143 gene-deficient mice.
Masukawa D, Nishizawa D, Kanai K, Kitamura S, Kasahara Y, Hashimoto T, Takahagi R, Hasegawa J, Nakayama K, Sato N, Tanioka F, Sugimura H, Ikeda K, Goshima Y. Masukawa D, et al. Among authors: hasegawa j. J Pharmacol Sci. 2020 Oct;144(2):89-93. doi: 10.1016/j.jphs.2020.07.003. Epub 2020 Jul 16. J Pharmacol Sci. 2020. PMID: 32763057 Free article.
1,207 results